Are they hanging on to QOF earnings?
Self-management programmes produce ‘clinically important benefits' in diabetes and hypertension, but not for osteoporosis, a meta-analysis concludes.
But the study – published in the latest Annals of Internal Medicine – cautioned it was still unclear precisely how self-
management was benefiting patients.
US researchers reviewed 53 self-management studies and found programmes for hypertension and diabetes reduced systolic blood pressure by 5mmHg, diastolic blood pressure by 4.3mmHg and HbA1c by about 0.81 per cent.
But self-management for osteoporosis had benefits that were ‘statistically significant but clinically trivial'.
Dr Mayur Lakhani, RCGP chair, called for self-management to be implemented more widely. ‘I am very clear patients want to be more involved in their care. What we have to do now is to research the best ways of making it happen.'Professor Anne Rogers, professor of the sociology of health care at the National Primary Care Research and Development Centre, University of Manchester, said: ‘The issue in the UK is we have to look at the context in which they're being introduced – does the way they're being introduced fit with the way primary care is organised?'